Complexity in Early Phase Clinical Trials with Dr. Oren Cohen
Clinical Trial Podcast | Conversations with Clinical Research Experts
00:00
Is the FDA Taking Advantage of Phase One Studies?
I think a lot of participants standpoint, the participants in her book felt like the industry was taking advantage of them. I would say there are very few of them that, that volunteer to that extent where they're where they have a significant income from it. A lot of them do multiple studies a year, but it's a couple, you know, it's maybe two or three studies a year. And they're grateful. You know, I have not encountered anybody who has been who's told me that they're that they feel taken advantage of nowmaybe they just wouldn't tell me that's very possible,. Yeah. It's certainly, it's certainly interesting phenomenon, but in any case,
Transcript
Play full episode
